Press Releases
Mimetogen Pharmaceuticals Announce the Appointment of David Guyer, M.D., to Board of Directors and Jay Stuart Pepose as Chief Medical Advisor
28 September 2021
Mimetogen pharmaceuticals completes enrollment of mim-728 phase 3 trial for tavilermide for dry eye disease
31 March 2020
Home
The Company
Management
Board of Directors
Clinical Advisors
About Dry Eye
Research & Technology
Clinical Development
News & Publications
Press Releases
Mimetogen in the News
Publications & Presentations